Sarepta Therapeutics Inc (SRPT)

Inventory turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 327,818 239,690 185,025 165,885 150,343 136,966 139,892 143,563 139,989 140,934 124,426 106,146 97,049 87,709 79,280 73,106 63,382 56,545 54,567 57,145
Inventory US$ in thousands 749,960 565,924 485,795 373,530 322,859 244,011 226,876 202,675 203,968 221,192 208,095 198,997 186,212 288,469 268,756 240,333 231,961 220,118 179,650 173,168
Inventory turnover 0.44 0.42 0.38 0.44 0.47 0.56 0.62 0.71 0.69 0.64 0.60 0.53 0.52 0.30 0.29 0.30 0.27 0.26 0.30 0.33

December 31, 2024 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $327,818K ÷ $749,960K
= 0.44

The inventory turnover ratio for Sarepta Therapeutics Inc has shown fluctuating trends over the past few years. The ratio was at its lowest in September 2020 at 0.26, indicating that the company took longer to sell its inventory during that period. However, there was a gradual improvement in the ratio from December 2020 to December 2022, reaching the highest point at the end of December 2022 with a ratio of 0.69. This suggests that the company was more efficient in managing and selling its inventory during this period.

Subsequently, there was a slight dip in the ratio from March 2023 to June 2024, falling to a low of 0.38 in June 2024. This could indicate potential issues with inventory management or a change in sales patterns during that period.

Overall, it is important for Sarepta Therapeutics Inc to closely monitor its inventory turnover ratio to ensure efficient management of inventory levels and timely sales to optimize working capital and profitability.